Korro Bio (NASDAQ:KRRO) is a biotechnology company focused on developing enzyme-based catalysts to drive sustainable solutions in the petrochemical and plastics industries. Headquartered in Pasadena, California, the company leverages proprietary protein engineering and high-throughput screening technologies to design catalysts that can selectively break down or transform hydrocarbon polymers. By harnessing the specificity of enzymes, Korro Bio seeks to enable more efficient and environmentally friendly processes for polymer upcycling, recycling, and chemical manufacturing.
The core offerings of Korro Bio center on tailored biocatalysts for polyethylene deconstruction and other polymer substrates. Its platform integrates computational modeling, directed evolution, and process engineering to advance enzyme performance under industrial conditions. Early pilots have demonstrated the ability of Korro Bio’s catalysts to function at elevated temperatures and in the presence of common additives, paving the way for integration into existing chemical production and waste-recovery facilities.
Since its founding in 2018, Korro Bio has expanded its footprint beyond the United States, collaborating with partners in Europe and Asia to validate its technology at larger scales. The company has forged strategic alliances with major chemical manufacturers and recycling firms to co-develop application-specific solutions, and it maintains a state-of-the-art research facility in California to support ongoing R&D activities.
Leadership at Korro Bio comprises a multidisciplinary team of scientists and industry executives with deep expertise in enzymology, polymer chemistry, and industrial biotechnology. The executive group includes veterans from leading biotech and chemical companies, supported by an advisory board of academic researchers in protein engineering and sustainable materials. Together, they are committed to advancing Korro Bio’s mission of transforming the lifecycle of petrochemical products through innovative biocatalysis.
